The global in-vitro fertilization market is set to reach from US$ 15,604.7 Mn in 2017 to US$ 36,854.0 Mn by 2026 expanding at a CAGR of 10.1% from 2018 to 2026.
Market Insights
Government healthcare institutes and hospitals are actively involved in providing funds to encourage egg and sperm freezing to bring down the rate of multiple pregnancies. Recent technological advancement in in-vitro fertilization technique such as Intracytoplasmic Sperm Injection (ICSI) and Assisted Reproductive Technology (ART) are being employed to increase the success rate of IVF treatment.
Browse the full report In-Vitro Fertilization Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/in-vitro-fertilization-market
Culture media are holding the largest market by instrument in the in-vitro fertilization market. Chief attributing factors are increased research activities in improving the culture media and its capability to preserve sperm cells without compromising on the quality drive the market growth for culture media. Strict regulatory mandates and urging need to maintain optimum sterile condition during IVF treatment will propel the market growth for disposable devices at a rapid pace.
Fresh non-donor is reigning the type segment for in-vitro fertilization market on account of the high success rate achieved during the first attempt of the treatment protocol. Frozen non-donor will be growing at a rapid pace in the near future owing to excellent live birth rate, lower miscarriage rate and reduced cases of ectopic pregnancy.
Fertility clinics are dominating the end-user segment for in-vitro fertilization market. Significant rise in couples opting for ART treatment and Gamete Intrafallopian Transfer (GIFT) drive the market growth for infertility clinics. Hospitals are showcasing steady growth on account of enhanced government funding to provide IVF treatment to poor families and rising public health awareness pertaining to infertility treatment.
North America is currently responsible for 35% share and is the leading regional segment for in-vitro fertilization market. Rising prevalence of infertility and the existence of highly sophisticated fertility clinics drive the market growth in the North America region. As per the research citings of American Society for Reproductive Medicine (ASRM), approximately 11.0% reproductive population suffer with infertility in the United States. Europe holds 30% market share on account of proactive government initiatives of providing financial aid for sponsoring the cost incurred during the IVF cycles. Asia Pacific represents 20% share owing to presence of large target population suffering with infertility. Adoption of sophisticated technology and low treatment cost further bolster the market growth in Asia Pacific region.
Biopharmaceuticals specializing in in-vitro fertilization market are Boston IVF, Cook Medical, Inc., Cooper Surgical, Inc., EMD Serono, Inc., Genea Biomedx, Irvine Scientific, Inc., OvaScience, Inc., Progyny, Inc., Thermo Fisher Scientific, Inc. and Vitrolife AB.
Key Market Movements:
- Rising prevalence of infertility and increasing trend of late child planning
- Technological advancement in the different treatment protocol pertaining to in-vitro fertilization
- Proactive government initiatives to establish fertility clinics and hospitals
Browse the full report In-Vitro Fertilization Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/in-vitro-fertilization-market
ToC:
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global IVF Market Portraiture
2.2. Global IVF Market, by Instrument, 2017 (US$ Mn)
2.3. Global IVF Market, by Type, 2017 (US$ Mn)
2.4. Global IVF Market, by End User, 2017 (US$ Mn)
2.5. Global IVF Market, by Geography, 2017 (US$ Mn)
Chapter 3. In-Vitro Fertilization (IVF) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global IVF Market, by Key Players, 2017
Chapter 4. Global In-Vitro Fertilization (IVF) Market, by Instrument
4.1. Overview
4.2. Disposable Devices
4.3. Culture Media
4.4. Capital Equipment
Chapter 5. Global In-Vitro Fertilization (IVF) Market, by Type
5.1. Overview
5.2. Fresh Donor
5.3. Frozen Donor
5.4. Fresh Non-Donor
5.5. Frozen Non-Donor
Chapter 6. Global In-Vitro Fertilization (IVF) Market, by End User
6.1. Overview
6.2. Fertility Clinics
6.3. Hospitals
Chapter 7. Global In-Vitro Fertilization (IVF) Market, by Geography
7.1. Overview
7.2. North America IVF Market Analysis, 2016 – 2026
7.2.1. North America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.2.2. North America IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.2.3. North America IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.2.4. North America IVF Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe IVF Market Analysis, 2016 – 2026
7.3.1. Europe IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.3.2. Europe IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.3.3. Europe IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.3.4. Europe IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific IVF Market Analysis, 2016 – 2026
7.4.1. Asia Pacific IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America IVF Market Analysis, 2016 – 2026
7.5.1. Latin America IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.5.2. Latin America IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.5.3. Latin America IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.5.4. Latin America IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East and Africa IVF Market Analysis, 2016 – 2026
7.6.1. MEA IVF Market, by Instrument, 2016 – 2026 (US$ Mn)
7.6.2. MEA IVF Market, by Type, 2016 – 2026 (US$ Mn)
7.6.3. MEA IVF Market, by End User, 2016 – 2026 (US$ Mn)
7.6.4. MEA IVF Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA
Chapter 8. Company Profiles
8.1. Boston IVF
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Cook Medical, Inc.
8.3. Cooper Surgical, Inc.
8.4. EMD Serono, Inc.
8.5. Genea Biomedx
8.6. Irvine Scientific, Inc.
8.7. OvaScience, Inc.
8.8. Progyny, Inc.
8.9. Thermo Fisher Scientific, Inc.
8.10. Vitrolife AB
Browse the full report In-Vitro Fertilization Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/in-vitro-fertilization-market
Related Reports:
Vitamin D Therapy Market By Route of Administration (Oral and Parenteral), By Application (Osteoporosis, Rickets, Autoimmune Disorder and Skin Disease) – Growth, Future Prospects & Competitive Analysis, 2019 – 2027
Media Contact
Company Name: Credence Research
Contact Person: Chris Smith
Email: Send Email
Phone: 18003618290
City: SAN JOSE
State: CA
Country: United States
Website: https://www.credenceresearch.com/report/in-vitro-fertilization-market